ACORN BIOVENTURES, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1766853. 1 Form 4 filing on record with FilingPulse; latest filed 2025-05-19.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2025-05-19 to 2025-05-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 1,400,000 shares, $2,590,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 1,129,730 shares @ $1.85 ($2,090,000) in OnKure Therapeutics, Inc., filed 2025-05-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | 10% owner | 1 | 2 legs · 1,400,000 sh · $2,590,000 | — | — |
Form 4 filings — ACORN BIOVENTURES, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-19 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with ACORN CAPITAL ADVISORS GP, LLC, Hove Anders D | Purchase (P): 270,270 @ $1.85 · Purchase (P): 1,129,730 @ $1.85 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1766853 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →